Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 5

1.

Effects of dalcetrapib in patients with a recent acute coronary syndrome.

Schwartz GG, Olsson AG, Abt M, Ballantyne CM, Barter PJ, Brumm J, Chaitman BR, Holme IM, Kallend D, Leiter LA, Leitersdorf E, McMurray JJ, Mundl H, Nicholls SJ, Shah PK, Tardif JC, Wright RS; dal-OUTCOMES Investigators.

N Engl J Med. 2012 Nov 29;367(22):2089-99. doi: 10.1056/NEJMoa1206797. Epub 2012 Nov 5.

PMID:
23126252
[PubMed - indexed for MEDLINE]
Free Article
2.

Effects of intravenous ibandronate injection on renal function in women with postmenopausal osteoporosis at high risk for renal disease--the DIVINE study.

Miller PD, Ragi-Eis S, Mautalen C, Ramirez F, Jonkanski I.

Bone. 2011 Dec;49(6):1317-22. doi: 10.1016/j.bone.2011.09.035. Epub 2011 Sep 16.

PMID:
21945737
[PubMed - indexed for MEDLINE]
3.

Intravenous ibandronate injections given every three months: a new treatment option to prevent bone loss in postmenopausal women.

Stakkestad JA, Benevolenskaya LI, Stepan JJ, Skag A, Nordby A, Oefjord E, Burdeska A, Jonkanski I, Mahoney P; Ibandronate Intravenous Study Group.

Ann Rheum Dis. 2003 Oct;62(10):969-75.

PMID:
12972476
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Oral weekly ibandronate prevents bone loss in postmenopausal women.

Tankó LB, Felsenberg D, Czerwiński E, Burdeska A, Jonkanski I, Hughes C, Christiansen C; Oral Ibandronate Group.

J Intern Med. 2003 Aug;254(2):159-67.

PMID:
12859697
[PubMed - indexed for MEDLINE]
5.

Efficacy and tolerability of moclobemide in comparison with placebo, tricyclic antidepressants, and selective serotonin reuptake inhibitors in elderly depressed patients: a clinical overview.

Amrein R, Stabl M, Henauer S, Affolter E, Jonkanski I.

Can J Psychiatry. 1997 Dec;42(10):1043-50.

PMID:
9469236
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk